Petitioner To Board: Patented Glaucoma Treatment Is Invalid

(March 15, 2022, 11:48 AM EDT) -- ALEXANDRIA, Va. — In a March 14 petition for inter partes review (IPR) filed with the Patent Trial and Appeal Board, a medical technology company says a single prior art reference “discloses everything claimed” in a patented device and technique for treating glaucoma....

Attached Documents

Related Sections